Modeling the development of panic disorder with interoceptive conditioning

Klara De Cort*, Mathias Schroijen, Rene Hurlemann, Suzanne Claassen, Jojanneke Hoogenhout, Omer Van den Bergh, Liesbet Goossens, Ilse Van Diest, Koen Schruers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)59-69
Number of pages11
JournalEuropean Neuropsychopharmacology
Volume27
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • Anxiety sensitivity
  • Panic disorder
  • Interoceptive
  • conditioning
  • Preparedness
  • 35% CO2
  • Pentagastrin
  • CARBON-DIOXIDE INHALATION
  • ANXIETY DISORDERS
  • AGONIST PENTAGASTRIN
  • RESPIRATORY BEHAVIOR
  • SOMATIC COMPLAINTS
  • DEPRESSION SCALE
  • FEAR
  • SENSITIVITY
  • METAANALYSIS
  • SYMPTOMS

Cite this

De Cort, K., Schroijen, M., Hurlemann, R., Claassen, S., Hoogenhout, J., Van den Bergh, O., ... Schruers, K. (2017). Modeling the development of panic disorder with interoceptive conditioning. European Neuropsychopharmacology, 27(1), 59-69. https://doi.org/10.1016/j.euroneuro.2016.11.001
De Cort, Klara ; Schroijen, Mathias ; Hurlemann, Rene ; Claassen, Suzanne ; Hoogenhout, Jojanneke ; Van den Bergh, Omer ; Goossens, Liesbet ; Van Diest, Ilse ; Schruers, Koen. / Modeling the development of panic disorder with interoceptive conditioning. In: European Neuropsychopharmacology. 2017 ; Vol. 27, No. 1. pp. 59-69.
@article{04dcf1fbbc8a4321a6c07a53358bab37,
title = "Modeling the development of panic disorder with interoceptive conditioning",
keywords = "Anxiety sensitivity, Panic disorder, Interoceptive, conditioning, Preparedness, 35{\%} CO2, Pentagastrin, CARBON-DIOXIDE INHALATION, ANXIETY DISORDERS, AGONIST PENTAGASTRIN, RESPIRATORY BEHAVIOR, SOMATIC COMPLAINTS, DEPRESSION SCALE, FEAR, SENSITIVITY, METAANALYSIS, SYMPTOMS",
author = "{De Cort}, Klara and Mathias Schroijen and Rene Hurlemann and Suzanne Claassen and Jojanneke Hoogenhout and {Van den Bergh}, Omer and Liesbet Goossens and {Van Diest}, Ilse and Koen Schruers",
year = "2017",
month = "1",
doi = "10.1016/j.euroneuro.2016.11.001",
language = "English",
volume = "27",
pages = "59--69",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "1",

}

De Cort, K, Schroijen, M, Hurlemann, R, Claassen, S, Hoogenhout, J, Van den Bergh, O, Goossens, L, Van Diest, I & Schruers, K 2017, 'Modeling the development of panic disorder with interoceptive conditioning', European Neuropsychopharmacology, vol. 27, no. 1, pp. 59-69. https://doi.org/10.1016/j.euroneuro.2016.11.001

Modeling the development of panic disorder with interoceptive conditioning. / De Cort, Klara; Schroijen, Mathias; Hurlemann, Rene; Claassen, Suzanne; Hoogenhout, Jojanneke; Van den Bergh, Omer; Goossens, Liesbet; Van Diest, Ilse; Schruers, Koen.

In: European Neuropsychopharmacology, Vol. 27, No. 1, 01.2017, p. 59-69.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Modeling the development of panic disorder with interoceptive conditioning

AU - De Cort, Klara

AU - Schroijen, Mathias

AU - Hurlemann, Rene

AU - Claassen, Suzanne

AU - Hoogenhout, Jojanneke

AU - Van den Bergh, Omer

AU - Goossens, Liesbet

AU - Van Diest, Ilse

AU - Schruers, Koen

PY - 2017/1

Y1 - 2017/1

KW - Anxiety sensitivity

KW - Panic disorder

KW - Interoceptive

KW - conditioning

KW - Preparedness

KW - 35% CO2

KW - Pentagastrin

KW - CARBON-DIOXIDE INHALATION

KW - ANXIETY DISORDERS

KW - AGONIST PENTAGASTRIN

KW - RESPIRATORY BEHAVIOR

KW - SOMATIC COMPLAINTS

KW - DEPRESSION SCALE

KW - FEAR

KW - SENSITIVITY

KW - METAANALYSIS

KW - SYMPTOMS

U2 - 10.1016/j.euroneuro.2016.11.001

DO - 10.1016/j.euroneuro.2016.11.001

M3 - Article

VL - 27

SP - 59

EP - 69

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 1

ER -

De Cort K, Schroijen M, Hurlemann R, Claassen S, Hoogenhout J, Van den Bergh O et al. Modeling the development of panic disorder with interoceptive conditioning. European Neuropsychopharmacology. 2017 Jan;27(1):59-69. https://doi.org/10.1016/j.euroneuro.2016.11.001